Other

Other medicaments, other active ingredients (residual category)

MEFCC CLEARANCE

HSN 3004 49 90 (Other medicaments) is subject to drug-import controls administered by the Ministry of Environment, Forest and Climate Change (MEFCC) and the Directorate General of Foreign Trade (DGFT) under ITC (HS) policy conditions for Chapter 30. Mandatory e-Sanchit documentation including a Registration Certificate for drugs (101dc1) and an Import Licence for drugs (9111dc) must be uploaded before customs out-of-charge. Import of oxytocin under this tariff line is prohibited, with a narrow carve-out for reference standards exclusively for test and analysis, subject to a test licence from DGCI/CDSCO.

What this is

HSN code

3004 49 90

Chapter

30 · Pharmaceutical products

Primary regulator

MEFCC · ITC (HS) policy conditions, Chapter 30; DGFT import policy

Customs documentation

Registration certificate (drugs) from CDSCO
Import licence for drugs from DGFT
Certificate of Analysis from manufacturer

Applicable Partner Government Agencies

MEFCCMEFCC·Ministry of Environment, Forest and Climate Change

Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.

Compliance steps

1
Ensure the drug or medicament holds a valid Registration Certificate for drugs and an Import Licence for drugs before the bill of entry is filed. Upload both documents in e-Sanchit under document codes 101dc1 (Registration Certificate) and 9111dc (Import Licence for drugs) alongside the Certificate of Analysis (0010dc), Batch Release Certificate (0030dc), and Label of Consignment (0110dc).
e-Sanchit mandatory documents: 0010dc, 0030dc, 0110dc, 101dc1, 9111dc — CCR for HSN 3004 49 90
2
Verify that the consignment does not contain oxytocin; import of oxytocin is prohibited under S.O. 2357(E) and DGFT Notification 09/2015-2020 both dated 23-05-2022. If the consignment is oxytocin reference standards imported exclusively for test and analysis, a test licence issued by DGCI/CDSCO must be obtained and presented before clearance.
S.O. 2357(E) dated 23-05-2022 · DGFT Notification 09/2015-2020 dated 23-05-2022
3
If the consignment comprises high-end or high-value used or refurbished medical equipment (other than critical care medical equipment as designated by DGHS), comply with the conditions prescribed in the Office Memorandum issued by the Ministry of Environment, Forest and Climate Change dated 15-12-2023 before filing the bill of entry.
O.M. issued by Ministry of Environment, Forest and Climate Change dated 15-12-2023

A word of counsel

The oxytocin prohibition is the most frequent source of consignment detention on this residual tariff line: importers occasionally include oxytocin-containing products under the broad 'Other' description without noticing the absolute prohibition under S.O. 2357(E). The sole exception — reference standards for test and analysis — requires a DGCI/CDSCO test licence uploaded in e-Sanchit before the bill of entry is assessed; absence of that licence results in confiscation and potential criminal liability under the Drugs and Cosmetics Act, 1940, not merely detention.

Need a regulatory steer on this product?

Speak to a regulatory counsel about your specific HSN, IS, and supplier situation.

Speak to an Expert

Frequently asked

Does HSN 3004 49 90 require BIS certification?

No, this residual medicaments tariff line is not within the BIS Quality Control Order regime. Import is governed by MEFCC and DGFT policy conditions for Chapter 30, with drug-specific clearances administered by DGCI/CDSCO covering registration, import licensing, and batch release.

Which document codes must be uploaded in e-Sanchit at the bill of entry for this HSN?

Five documents are mandatory: Certificate of Analysis — Drug (0010dc), Batch Release Certificate (0030dc), Label of Consignment (0110dc), Registration Certificate for drugs (101dc1), and Import Licence for drugs (9111dc); all must be uploaded before out-of-charge is granted.

Can oxytocin reference standards be imported under HSN 3004 49 90?

Yes, but exclusively for test and analysis purposes; a test licence issued by DGCI/CDSCO is a condition precedent to import, per S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022. Commercial import of oxytocin under this tariff line remains prohibited without exception.

Last verified against gazette notifications: 2026-05-16. Source: MEFCC / DGFT / Indian Customs CUSDATA.